These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 16271887)

  • 1. Crystal structure of a complex between protein tyrosine phosphatase 1B and the insulin receptor tyrosine kinase.
    Li S; Depetris RS; Barford D; Chernoff J; Hubbard SR
    Structure; 2005 Nov; 13(11):1643-51. PubMed ID: 16271887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domain.
    Lee CC; Jia Y; Li N; Sun X; Ng K; Ambing E; Gao MY; Hua S; Chen C; Kim S; Michellys PY; Lesley SA; Harris JL; Spraggon G
    Biochem J; 2010 Sep; 430(3):425-37. PubMed ID: 20632993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of phosphocaveolin-1 as a novel protein tyrosine phosphatase 1B substrate.
    Lee H; Xie L; Luo Y; Lee SY; Lawrence DS; Wang XB; Sotgia F; Lisanti MP; Zhang ZY
    Biochemistry; 2006 Jan; 45(1):234-40. PubMed ID: 16388599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of insulin-like growth factor I receptor tyrosine kinase by ethanol.
    Rubin R; Harrison R; Chen XF; Corzitotto J; Hoek JB; Hallak H
    Biochem Pharmacol; 2004 Nov; 68(10):2009-17. PubMed ID: 15476672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular dynamics studies on the interactions of PTP1B with inhibitors: from the first phosphate-binding site to the second one.
    Wang JF; Gong K; Wei DQ; Li YX; Chou KC
    Protein Eng Des Sel; 2009 Jun; 22(6):349-55. PubMed ID: 19380334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective protein tyrosine phosphatase 1B inhibitors: targeting the second phosphotyrosine binding site with non-carboxylic acid-containing ligands.
    Liu G; Xin Z; Liang H; Abad-Zapatero C; Hajduk PJ; Janowick DA; Szczepankiewicz BG; Pei Z; Hutchins CW; Ballaron SJ; Stashko MA; Lubben TH; Berg CE; Rondinone CM; Trevillyan JM; Jirousek MR
    J Med Chem; 2003 Jul; 46(16):3437-40. PubMed ID: 12877578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of phosphotyrosine phosphatase 1B causes resistance in BCR-ABL-positive leukemia cells to the ABL kinase inhibitor STI571.
    Koyama N; Koschmieder S; Tyagi S; Portero-Robles I; Chromic J; Myloch S; Nürnberger H; Rossmanith T; Hofmann WK; Hoelzer D; Ottmann OG
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2025-31. PubMed ID: 16609011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residue 259 in protein-tyrosine phosphatase PTP1B and PTPalpha determines the flexibility of glutamine 262.
    Peters GH; Iversen LF; Andersen HS; Møller NP; Olsen OH
    Biochemistry; 2004 Jul; 43(26):8418-28. PubMed ID: 15222753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The structural basis for the selectivity of benzotriazole inhibitors of PTP1B.
    Scapin G; Patel SB; Becker JW; Wang Q; Desponts C; Waddleton D; Skorey K; Cromlish W; Bayly C; Therien M; Gauthier JY; Li CS; Lau CK; Ramachandran C; Kennedy BP; Asante-Appiah E
    Biochemistry; 2003 Oct; 42(39):11451-9. PubMed ID: 14516196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane localization of protein-tyrosine phosphatase 1B is essential for its activation of sterol regulatory element-binding protein-1 gene expression and consequent hypertriglyceridaemia.
    Ugi S; Shi K; Nishio Y; Shimizu S; Guo B; Sekine O; Ikeda K; Egawa K; Yoshizaki T; Nagai Y; Koya D; Takada T; Torii R; Kimura H; Kashiwagi A; Maegawa H
    J Biochem; 2009 Oct; 146(4):541-7. PubMed ID: 19605464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The focal adhesion targeting domain of focal adhesion kinase contains a hinge region that modulates tyrosine 926 phosphorylation.
    Prutzman KC; Gao G; King ML; Iyer VV; Mueller GA; Schaller MD; Campbell SL
    Structure; 2004 May; 12(5):881-91. PubMed ID: 15130480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein tyrosine phosphatase regulation in fibroblasts from patients with an insulin receptor gene mutation.
    Seki N; Yagi S; Suzuki Y; Shimada F; Taira M; Makino H; Amano K; Yagui K; Saito Y; Hashimoto N
    Horm Metab Res; 2008 Dec; 40(12):833-7. PubMed ID: 18925540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus.
    Koren S; Fantus IG
    Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):621-40. PubMed ID: 18054739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane localization of protein-tyrosine phosphatase 1B is essential for its activation of sterol regulatory element-binding protein-1 gene expression.
    Shi K; Ugi S; Shimizu S; Sekine O; Ikeda K; Egawa K; Yoshizaki T; Nagai Y; Nishio Y; Takada T; Torii R; Kimura H; Kashiwagi A; Maegawa H
    Biochem Biophys Res Commun; 2007 Nov; 363(3):626-32. PubMed ID: 17897622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dinuclear copper complexes of organic claw: potent inhibition of protein tyrosine phosphatases.
    Ma L; Lu L; Zhu M; Wang Q; Gao F; Yuan C; Wu Y; Xing S; Fu X; Mei Y; Gao X
    J Inorg Biochem; 2011 Sep; 105(9):1138-47. PubMed ID: 21708098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based optimization of protein tyrosine phosphatase 1B inhibitors: from the active site to the second phosphotyrosine binding site.
    Wilson DP; Wan ZK; Xu WX; Kirincich SJ; Follows BC; Joseph-McCarthy D; Foreman K; Moretto A; Wu J; Zhu M; Binnun E; Zhang YL; Tam M; Erbe DV; Tobin J; Xu X; Leung L; Shilling A; Tam SY; Mansour TS; Lee J
    J Med Chem; 2007 Sep; 50(19):4681-98. PubMed ID: 17705360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steered Molecular Dynamics for Investigating the Interactions Between Insulin Receptor Tyrosine Kinase (IRK) and Variants of Protein Tyrosine Phosphatase 1B (PTP1B).
    Nguyen H; Do N; Phan T; Pham T
    Appl Biochem Biotechnol; 2018 Feb; 184(2):401-413. PubMed ID: 28707052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between the insulin receptor and Grb14: a dynamic study in living cells using BRET.
    Nouaille S; Blanquart C; Zilberfarb V; Boute N; Perdereau D; Burnol AF; Issad T
    Biochem Pharmacol; 2006 Nov; 72(11):1355-66. PubMed ID: 16934761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of the mechanism of selectivity of protein tyrosine phosphatase 1B (PTP1B) bidentate inhibitors using molecular dynamics simulations and free energy calculations.
    Fang L; Zhang H; Cui W; Ji M
    J Chem Inf Model; 2008 Oct; 48(10):2030-41. PubMed ID: 18831546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential sorting of tyrosine kinases and phosphotyrosine phosphatases acting on band 3 during vesiculation of human erythrocytes.
    Minetti G; Ciana A; Balduini C
    Biochem J; 2004 Jan; 377(Pt 2):489-97. PubMed ID: 14527338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.